| 2025 | 三变科技股份有限公司 年半年度报告摘要 | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 证券代码：002112 | 证券简称：三变科技 公告编号：2025-050 | | | | | | | 2025 三变科技股份有限公司 年半年度报告摘要 | | | | | | | | 三变科技股份有限公司 | | | | | | 2025 年半年度报告摘要 | | 一、重要提示 | | | | | | | | 本半年度报告摘要来自半年度报告全文，为全面了解本公司的经营成果、财务状况及未来 | | | | | | | | 发展规划，投资者应当到证监会指定媒体仔细阅读半年度报告全文。 | | | | | | | | 所有董事均已出席了审议本报告的董事会会议。 | | | | | | | | 非标准审计意见提示 | | | | | | | | □适用 ?不适用 | | | | | | | | 董事会审议的报告期利润分配预案或公积金转增股本预案 | | | | | | | | □适用 ?不适用 | | | | | | | | 公司计划不派发现金 ...

"股东大会授权董事会全权办理本次向特定对象发行 A 股股票（"本次发 行"）的相关事项，包括但不限于： （1）授权董事会选任、聘请保荐机构、律师事务所、会计师事务所、财务 顾问、验资机构等中介机构，具体承办本次发行的有关工作； （2）授权董事会代表本公司与证券监督管理机构、证券交易机构、证券登 记结算机构依法进行沟通，依法履行申报、审核程序，根据证监会、深交所等证 券监管部门的要求制作、申报本次发行的申请文件，并根据证券监管部门的反馈 意见回复相关问题、修订和补充相关申请文件； （3）根据具体情况制定和实施本次发行的具体方案，授权董事会在经股东 大会批准的发行方案框架内，根据证券市场行情以及相关政策环境的具体情况， 与保荐机构（主承销商）协商确定或调整发行时机、发行时间、发行价格、发行 数量、发行对象选择条件，及时酌情调整经股东大会批准的发行方案或发行定价 基准日，在股东大会决议范围内对募集资金用途的具体安排进行调整； 股票代码：002842 股票简称：翔鹭钨业 公告编号：2025-071 关于延长公司向特定对象发行 A 股股票股东会决议有 效期及相关授权有效期的公告 本公司及董事会全体成员保证信息披露内容的 ...

证券代码：300903 证券简称：科翔股份 公告编号：2025-048 广东科翔电子科技股份有限公司 规、部门规章、规范性文件和《公司章程》的规定。 （1）现场会议召开的时间：2025 年 9 月 1 日（星期一）下午 15:00 （2）网络投票时间：2025 年 9 月 1 日（星期一） 其中，通过深圳证券交易所交易系统进行网络投票的具体时间为 2025 年 9 月 1 日的交易时间，即 9:15 至 9:25，9:30 至 11:30 和 13:00 至 15:00； 通过深圳证券交易所互联网投票系统投票的具体时间为 2025 年 9 月 1 日 （1）现场投票：股东本人出席现场会议或者通过授权委托书（详见附件一） 委托他人出席现场会议。 （2）网络投票：公司将通过深交所交易系统和互联网投票系统 (http://wltp.cninfo.com.cn)向公司股东提供网络形式的投票平台，股权登记日登记 在册的公司股东可在网络投票时间内通过上述系统行使表决权。 本次股东会，公司股东应选择现场投票、网络投票中的一种方式，如果同一 表决权出现重复表决的以第一次投票结果为准。 本公司及董事会全体成员保证信息披露的内容 ...

特此公告。 广东科翔电子科技股份有限公司 董事会 证券代码：300903 证券简称：科翔股份 公告编号：2025-051 广东科翔电子科技股份有限公司 本公司及董事会全体成员保证公告内容真实、准确和完整，不存在任何虚假记 载、误导性陈述或者重大遗漏。 广东科翔电子科技股份有限公司（以下简称"公司"）于 2025 年 8 月 14 日 召开第三届董事会第二次会议，审议通过了关于公司 2025 年度以简易程序向特 定对象发行股票的相关议案。现就本次以简易程序向特定对象发行股票中，公司 不存在直接或通过利益相关方向参与认购的投资者提供财务资助或补偿事宜承 诺如下： 公司不会向本次参与认购的投资者作出保底保收益或变相保底保收益承诺， 不会直接或通过利益相关方向本次参与认购的投资者提供财务资助或补偿。 关于2025年度以简易程序向特定对象发行股票不存在直接或通过利 益相关方向参与认购的投资者提供财务资助或补偿的公告 ...

气派科技公告，公司2025年度向特定对象发行A股股票的发行对象为梁大钟、白瑛和梁华特，发行价格 为20.11元/股，发行数量不超过790万股，拟募集资金总额不超过1.59亿元，扣除发行费用后将全部用于 补充流动资金。本次发行构成关联交易，不会导致公司控制权发生变化。 ...

Group 1 - The board of directors of Jiangsu Farsen Co., Ltd. held a meeting to discuss and approve several key matters, including the revision of the 2025 stock issuance plan due to a transfer of shares among controlling shareholders [1][2] - The independent directors held a special meeting to review and approve the revised stock issuance plan and the report on the use of previously raised funds, with all votes in favor [2][4] - The company engaged Zhongxinghua Accounting Firm to audit its internal control and issue relevant reports, which were also approved by the audit committee with unanimous support [3][4] Group 2 - The company provided detailed explanations regarding the use of previously raised funds, which were verified by Zhongxinghua Accounting Firm, and the report was approved by the independent directors [4][5] - The audit reports for the years 2022 to 2024 were issued by Zhongxinghua Accounting Firm, receiving unanimous approval from the audit committee [3][5] - The company also prepared a report on non-recurring gains and losses for the recent three years, which was reviewed and approved by the audit committee [5]

Group 1 - The supervisory board of Jiangsu Farsen Co., Ltd. held a meeting on August 8, 2025, to discuss and approve several key matters, including the revision of the 2025 stock issuance plan due to a transfer of shares among its controlling shareholders [1][2] - The independent directors of the company also approved the revised stock issuance plan, with a unanimous vote of 5 in favor, 0 against, and 0 abstentions [2] - The company engaged Zhongxinghua Accounting Firm to audit its internal control and issued a report on the internal control evaluation for the first quarter of 2025, which was also approved by the audit committee with the same voting results [2][3] Group 2 - The company prepared a report on the use of previously raised funds, which was verified by Zhongxinghua Accounting Firm, and the independent directors approved this report with a unanimous vote [3] - The details of the revised stock issuance plan and the previous fundraising usage report were disclosed on the company's official website [1][3]

Core Viewpoint - Huizhou Guanghong Technology Co., Ltd. is planning to issue shares to specific investors, with the aim of expanding its business and enhancing its competitive position in the electronic manufacturing services (EMS) sector. Group 1: Company Overview - Company Name: Huizhou Guanghong Technology Co., Ltd. [3] - Stock Code: 300735 [3] - Registered Capital: 76,746.0689 million RMB [3] - Established: March 24, 1995 [3] - Listed: December 29, 2017 [3] - Main Business: Specializes in assembly of electronic products in consumer electronics, automotive electronics, network communications, and new energy sectors, providing comprehensive EMS [4][3]. Group 2: Financial Performance - Revenue for the first quarter of 2025: 119,578.80 million RMB, a significant increase from 688,141.22 million RMB in 2024 and 540,244.90 million RMB in 2023 [6]. - Net profit for the first quarter of 2025: 3,085.54 million RMB, compared to 34,240.68 million RMB in 2024 [6]. - The company’s revenue composition shows that consumer electronics accounted for 63.59% of total revenue in the latest reporting period [4]. Group 3: Business Strategy and Growth - The company is actively expanding into the automotive electronics sector, with revenue from this segment increasing significantly in 2023 [4]. - Recent acquisitions include the purchase of Fastboard Electronics Technology (Shanghai) Co., Ltd. in April 2023 and AC Company, a French automotive electronics EMS firm, in May 2025 [4]. - The company aims to leverage these acquisitions to enhance its service offerings and customer base in telecommunications, automotive electronics, and industrial control sectors [4]. Group 4: Share Issuance Details - The share issuance will involve up to 230,238,206 shares, not exceeding 30% of the total share capital prior to the issuance [17]. - The total amount to be raised is capped at 103,294.48 million RMB, with net proceeds allocated to specific projects [17]. - The issuance will be directed towards no more than 35 specific investors, including various financial institutions and qualified investors [16].

Group 1 - The company, Shanxi Yongdong Chemical Co., Ltd., received a second round inquiry letter from Shenzhen Stock Exchange regarding its application for a specific object stock issuance on July 9, 2025 [1] - The company, along with relevant intermediaries, conducted a thorough study and addressed the questions raised in the inquiry letter, with detailed responses disclosed on July 18, 2025 [1][2] - The stock issuance is subject to approval from both the Shenzhen Stock Exchange and the China Securities Regulatory Commission, with uncertainties regarding the approval timeline [2] Group 2 - The company will fulfill its information disclosure obligations based on the progress of the stock issuance matter, urging investors to make cautious decisions [2]

证券代码：002653 证券简称：海思科 公告编号：2025-090 海思科医药集团股份有限公司 公司收到审核问询函后，会同相关中介机构对审核问询函所列问 题进行逐项回复和说明，同时对募集说明书等申请文件进行补充和更 新，具体内容详见公司在巨潮资讯网（www.cninfo.com.cn）披露的相 关文件。 公司本次向特定对象发行股票事项尚需通过深交所审核，并获得 中国证券监督管理委员会（以下简称"中国证监会"）同意注册后方 可实施，最终是否能通过深交所审核，并获得中国证监会同意注册的 决定及其时间尚存在不确定性。 公司将根据该事项进展情况，按照有关规定和要求及时履行信息 披露义务，敬请广大投资者注意投资风险。 特此公告。 关于向特定对象发行股票的审核问询函回复 及募集说明书等申请文件修订的提示性公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 海思科医药集团股份有限公司（以下简称"公司"）于 2025 年 海思科医药集团股份有限公司申请向特定对象发行股票的审核问询 函》（审核函〔2025〕120027 号）。深交所发行上市审核机构对公司 向特定对象发行股票 ...